Khosrow Adeli Selected Research

Apolipoprotein B-48

10/2015	Glucagon-Like Peptide 2 (GLP-2) Stimulates Postprandial Chylomicron Production and Postabsorptive Release of Intestinal Triglyceride Storage Pools via Induction of Nitric Oxide Signaling in Male Hamsters and Mice.
9/2015	Intestinal scavenger receptor class B type I as a novel regulator of chylomicron production in healthy and diet-induced obese states.
11/2009	Cinnamon extract inhibits the postprandial overproduction of apolipoprotein B48-containing lipoproteins in fructose-fed animals.
9/2009	Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36.
5/2006	Intestinal insulin resistance and aberrant production of apolipoprotein B48 lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia: evidence for activation of protein tyrosine phosphatase-1B, extracellular signal-related kinase, and sterol regulatory element-binding protein-1c in the fructose-fed hamster intestine.
2/2004	Insulin regulates hepatic apolipoprotein B production independent of the mass or activity of Akt1/PKBalpha.
8/2002	Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Khosrow Adeli Research Topics

Disease

58	Insulin Resistance 01/2020 - 01/2002
42	Dyslipidemias (Dyslipidemia) 01/2022 - 03/2002
20	Metabolic Syndrome (Dysmetabolic Syndrome X) 03/2017 - 09/2003
17	Obesity 01/2022 - 06/2007
16	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2002
13	Hypertriglyceridemia 09/2015 - 03/2002
12	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2006
12	Inflammation (Inflammations) 01/2019 - 03/2008
9	Hyperlipidemias (Hyperlipidemia) 01/2020 - 07/2002
8	COVID-19 01/2022 - 01/2020
6	Neoplasms (Cancer) 10/2022 - 12/2008
6	Hyperinsulinism (Hyperinsulinemia) 01/2020 - 04/2002
5	Fatty Liver 01/2018 - 12/2008
5	Hyperglycemia 01/2017 - 04/2002
5	Atherosclerosis 06/2012 - 06/2006
5	Hepatocellular Carcinoma (Hepatoma) 10/2008 - 02/2004
3	Heart Failure 01/2021 - 02/2011
3	Hemorrhage 02/2020 - 05/2005
3	Overweight 01/2020 - 11/2007
3	Metabolic Diseases (Metabolic Disease) 10/2019 - 09/2015
3	Glucose Intolerance 12/2017 - 08/2009
3	Weight Gain 09/2015 - 12/2004
3	Body Weight (Weight, Body) 12/2014 - 11/2009
3	Hypercholesterolemia 05/2012 - 10/2006
2	Myocardial Infarction 01/2021 - 01/2018
2	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 02/2020
2	Non-alcoholic Fatty Liver Disease 01/2019 - 01/2018
2	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018 - 05/2012
2	Diabetic Nephropathies (Diabetic Nephropathy) 06/2014 - 03/2011
2	Lecithin Cholesterol Acyltransferase Deficiency (Lecithin:Cholesterol Acyltransferase Deficiency) 06/2012 - 08/2007
2	Craniopharyngioma (Craniopharyngiomas) 08/2011 - 05/2010
2	Abdominal Obesity 11/2008 - 03/2007

Drug/Important Bio-Agent (IBA)

55	Insulin (Novolin)FDA Link 01/2022 - 01/2002
32	Lipoproteins (Lipoprotein)IBA 01/2020 - 03/2002
29	LipidsIBA 01/2021 - 11/2004
29	FructoseIBA 11/2020 - 01/2002
15	Triglycerides (Triacylglycerol)IBA 01/2021 - 03/2002
13	Glucose (Dextrose)FDA LinkGeneric 06/2021 - 03/2002
13	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2002
13	Apolipoproteins B (ApoB)IBA 08/2011 - 01/2002
12	Biomarkers (Surrogate Marker)IBA 09/2022 - 06/2006
11	VLDL LipoproteinsIBA 01/2018 - 01/2002
10	ChylomicronsIBA 10/2017 - 02/2007
10	ApolipoproteinsIBA 05/2010 - 01/2003
8	CholesterolIBA 01/2021 - 08/2009
7	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 02/2013
7	Apolipoprotein B-48IBA 10/2015 - 08/2002
5	AntigensIBA 01/2022 - 12/2014
5	Tyrosine (L-Tyrosine)FDA Link 03/2010 - 04/2002
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2008 - 03/2002
4	C-Reactive ProteinIBA 01/2022 - 03/2007
4	Messenger RNA (mRNA)IBA 12/2017 - 08/2009
4	HDL LipoproteinsIBA 09/2012 - 03/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2010 - 02/2007
4	HDL CholesterolIBA 08/2007 - 03/2002
4	Nonesterified Fatty Acids (NEFA)IBA 06/2006 - 04/2002
3	EnzymesIBA 09/2022 - 01/2017
3	TroponinIBA 01/2022 - 01/2021
3	Natriuretic PeptidesIBA 01/2022 - 02/2011
3	Dietary Fats (Dietary Fat)IBA 01/2020 - 08/2009
3	LDL Receptors (LDL Receptor)IBA 01/2018 - 09/2009
3	IncretinsIBA 07/2015 - 02/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 05/2015 - 05/2005
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2014 - 03/2006
3	LeptinIBA 11/2010 - 11/2008
3	CytokinesIBA 09/2009 - 02/2007
3	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 08/2009 - 01/2002
3	Insulin ReceptorIBA 08/2009 - 04/2002
3	Rosiglitazone (Avandia)FDA Link 01/2005 - 08/2002
2	Ferritins (Ferritin)IBA 01/2022 - 01/2018
2	Biological ProductsIBA 12/2021 - 09/2015
2	AntibodiesIBA 12/2021 - 10/2020
2	Immunoglobulin G (IgG)IBA 12/2021 - 01/2018
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021 - 02/2011
2	Bile Acids and Salts (Bile Acids)IBA 01/2020 - 01/2020
2	Glucagon-Like Peptide-1 ReceptorIBA 01/2020 - 12/2014
2	Exenatide (Byetta)FDA Link 01/2020 - 12/2014
2	Peptides (Polypeptides)IBA 01/2020 - 12/2014
2	Pharmaceutical PreparationsIBA 10/2019 - 03/2011
2	Glucagon-Like Peptide-2 ReceptorIBA 01/2019 - 01/2018
2	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2019 - 07/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 11/2010
2	Apolipoproteins AIBA 01/2018 - 11/2007
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2018 - 12/2014
2	VitaminsIBA 01/2018 - 06/2014
2	Testosterone (Sustanon)FDA Link 01/2018 - 07/2014
2	Sterol Regulatory Element Binding Protein 1IBA 12/2017 - 05/2013
2	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 08/2013
2	CarbohydratesIBA 12/2014 - 06/2006
2	SterolsIBA 01/2013 - 05/2006
2	LDL Lipoproteins (beta Lipoproteins)IBA 09/2012 - 03/2002
2	GhrelinIBA 08/2011 - 11/2008
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2011 - 04/2010
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2010 - 05/2005
2	AdipokinesIBA 05/2010 - 09/2009
2	oxidized low density lipoproteinIBA 09/2009 - 03/2002
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2008 - 06/2006
2	Protein Kinases (Protein Kinase)IBA 10/2008 - 06/2006

Therapy/Procedure

10	Therapeutics 10/2022 - 04/2006
2	Personal Protective Equipment 12/2020 - 01/2020